The Inherent Coupling of Intrinsically Disordered Regions in the Multidomain Receptor Tyrosine Kinase KIT

The Inherent Coupling of Intrinsically Disordered Regions in the Multidomain Receptor Tyrosine Kinase KIT

RTK KIT regulates a variety of crucial cellular processes via its cytoplasmic domain (CD), which is composed of the tyrosine kinase domain, crowned by the highly flexible domains—the juxtamembrane region, kinase insertion domain, and C-tail, which are key recruitment regions for downstream signallin...

Full description

Bibliographic Details
Main Authors:	Julie Ledoux, Alain Trouvé, Luba Tchertanov
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	International Journal of Molecular Sciences
Subjects:	receptor tyrosine kinase (RTK) full-length KIT cytoplasmic region intrinsically disordered regions phosphotyrosine modelling molecular dynamics
Online Access:	https://www.mdpi.com/1422-0067/23/3/1589

Similar Items

Folding and Intrinsic Disorder of the Receptor Tyrosine Kinase KIT Insert Domain Seen by Conventional Molecular Dynamics Simulations
by: Julie Ledoux, et al.
Published: (2021-07-01)

Does Generic Cyclic Kinase Insert Domain of Receptor Tyrosine Kinase KIT Clone Its Native Homologue?
by: Julie Ledoux, et al.
Published: (2022-10-01)

IQGAP1 Is a Phosphotyrosine-Regulated Scaffold for SH2-Containing Proteins
by: Louise Thines, et al.
Published: (2023-02-01)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance <break/>Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma
by: Mohamad Krayem, et al.
Published: (2020-02-01)

Role and significance of c-KIT receptor tyrosine kinase in cancer: A review
by: Emana Sheikh, et al.
Published: (2022-09-01)

Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53
by: Chan, Jane Vin, et al.
Published: (2018)

c-Kit Induces Migration of Triple-Negative Breast Cancer Cells and Is a Promising Target for Tyrosine Kinase Inhibitor Treatment
by: José A. López-Mejía, et al.
Published: (2022-08-01)

ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications
by: Flavia Linguanti, et al.
Published: (2023-12-01)

A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics
by: Elizabeth M Steenkiste, et al.
Published: (2021-06-01)

Protein-tyrosine phosphorylation in Bacillus subtilis: a 10-year retrospective
by: Josef eDeutscher, et al.
Published: (2015-01-01)

Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary <i>KIT</i> Mutations
by: Sergei Boichuk, et al.
Published: (2023-11-01)

High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display
by: Allyson Li, et al.
Published: (2023-03-01)

Novel approaches to treating advanced systemic mastocytosis
by: Gilreath JA, et al.
Published: (2019-07-01)

Hepatitis C Virus Core Protein Down-Regulates Expression of Src-Homology 2 Domain Containing Protein Tyrosine Phosphatase by Modulating Promoter DNA Methylation
by: Priya Devi, et al.
Published: (2021-12-01)

Allosteric communication across the native and mutated KIT receptor tyrosine kinase.
by: Elodie Laine, et al.
Published: (2012-01-01)

Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
by: Miguel Piris-Villaespesa, et al.
Published: (2020-04-01)

Hereditable variants of classical protein tyrosine phosphatase genes: Will they prove innocent or guilty?
by: Wiljan J. A. J. Hendriks, et al.
Published: (2023-01-01)

Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes
by: Klopfleisch Robert, et al.
Published: (2012-06-01)

Functional selectivity of Receptor Tyrosine Kinases regulates distinct cellular outputs
by: Sakim S. Samad, et al.
Published: (2024-01-01)

Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
by: Lea Scherschinski, et al.
Published: (2022-01-01)

Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
by: Abbaspour Babaei M, et al.
Published: (2016-08-01)

Protein intrinsically disordered region prediction by combining neural architecture search and multi-objective genetic algorithm
by: Yi-Jun Tang, et al.
Published: (2023-09-01)

Intrinsically Disordered Proteins: An Overview
by: Rakesh Trivedi, et al.
Published: (2022-11-01)

Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells
by: Menna El Gaafary, et al.
Published: (2022-12-01)

SH2 Domains: Folding, Binding and Therapeutical Approaches
by: Awa Diop, et al.
Published: (2022-12-01)

The effect of phospho-peptide on the stability of gold nanoparticles and drug delivery
by: Zhanwu Hou, et al.
Published: (2019-08-01)

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
by: Kallen Schwark, et al.
Published: (2022-08-01)

Low Complexity Induces Structure in Protein Regions Predicted as Intrinsically Disordered
by: Mariane Gonçalves-Kulik, et al.
Published: (2022-08-01)

RTK Inhibitors in Melanoma: From Bench to Bedside
by: Malak Sabbah, et al.
Published: (2021-04-01)

Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors
by: Xuechao Liu, et al.
Published: (2019-10-01)

Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions
by: Aysan Moeinafshar, et al.
Published: (2024-01-01)

Inhibition of FGF2-Mediated Signaling in GIST—Promising Approach for Overcoming Resistance to Imatinib
by: Sergei Boichuk, et al.
Published: (2020-06-01)

Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD
by: Marie Schwarz, et al.
Published: (2022-11-01)

Compositional Bias of Intrinsically Disordered Proteins and Regions and Their Predictions
by: Bi Zhao, et al.
Published: (2022-06-01)

Functional Tuning of Intrinsically Disordered Regions in Human Proteins by Composition Bias
by: Kristina Kastano, et al.
Published: (2022-10-01)

Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling
by: Won-Sik Shin, et al.
Published: (2023-07-01)

The Characteristics of Intrinsic Fluorescence of Type I Collagen Influenced by Collagenase I
by: Yiming Shen, et al.
Published: (2018-10-01)

Redox-Regulated Pathway of Tyrosine Phosphorylation Underlies NF-κB Induction by an Atypical Pathway Independent of the 26S Proteasome
by: Sarah Cullen, et al.
Published: (2015-02-01)

Intrinsically disordered proteins studied by NMR spectroscopy
by: Marco Schiavina, et al.
Published: (2024-03-01)

In silico study of intrinsic dynamics of full-length apo-ACE2 and RBD-ACE2 complex
by: Qing Liu, et al.
Published: (2021-01-01)